Drug Discovery

Cancer cells
#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

New webinar: Tackling drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

#News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events

Certificate of attendance: Drug Discovery Innovators & Investors Digital Forum

With less than a month to go, the Drug Discovery Innovators & Investors (DDII) Digital Forum will bring together leaders and experts from across the drug discovery ecosystem on 30 September 2026 to explore the technologies, strategies, therapies and investment trends shaping the future of early-stage drug discovery. Across four… Read More

#News

#Automation #Chromatography #Drug discovery #Webinar

How to increase throughput with chromatography & automation

Join this webinar, “Rethinking protein purification: How to increase throughput with parallel chromatography and automation”, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (17-21 August 2026) 

News round-up for 17-21 August by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new therapeutic approaches moving towards or through clinical development, alongside advances in drug discovery and the investment landscape supporting biotech innovation. The top stories:  DDII Digital Forum:… Read More

#News

Tumour microenvironment
#Akiram Therapeutics #Cancer research #Drug development #Radionuclide therapy #Radiopharmaceuticals #Solid tumours

Partnership supports radiopharmaceutical solid tumour development

Akiram Therapeutics has signed an agreement with ITM for the supply of non-carrier-added lutetium-177 (n.c.a. Lu-177) to support the ongoing clinical trial of AKIR001, its lead radiopharmaceutical candidate for the treatment of solid tumours. Lu-177 is one of the most widely used medical radioisotopes in targeted radionuclide therapy and serves… Read More

#News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events

Drug Discovery Innovators & Investors digital forum: Resilience, smarter labs, therapeutics, and capital flows

The Drug Discovery Innovators & Investors (DDII) Digital Forum, taking place on 30 September 2026, will bring together experts from across the drug discovery ecosystem to examine the scientific, operational and commercial developments shaping the future of early-stage drug discovery. Following the announcement of the preliminary speaker lineup, we… Read More

#News

#Cellular biology #Clinical research #Drug discovery #Insilico Medicine #Virtual Aging Cell (VAC) #Virtual cell research

Insilico advances virtual cell research

Insilico Medicine has introduced biological age as a core condition in virtual cell research with the launch of its Virtual Aging Cell (VAC) Webpage and a preview of its Multi-Agent driven VAC platform. The clinical-stage drug discovery company said the platform represents the industry’s first multi-agent Virtual Aging Cell platform… Read More

#News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Register now: Webinar on rethinking protein purification

Join this webinar, hosted by DDW and supported by Cytiva to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

#Animal models #Clinical trials #Drug discovery #New approach methodologies (NAMs)

A turning point for human-based drug discovery

Daniel Delubac, Chief Executive Officer at iOrganBio looks at how technologies that mimic human behaviour can improve drug discovery efforts past animal models.   The US is signalling a decisive shift toward human-based drug discovery. In March, the National Institutes… Read More

#Exclusive Content

Leukaemia
#Acute Myeloid Leukaemia #Cancer research #Drug discovery #Oncology

New drug target discovered for acute myeloid leukaemia 

Researchers have identified a new target for an aggressive type of blood cancer, offering a promising treatment option that could keep patients well for longer, with fewer side effects.  Scientists at The Institute of Cancer Research, London, and The University of Edinburgh, discovered that blocking the TUT4/7 enzymes can significantly halt… Read More

#News

Cancer tumour
#Cancer vaccines #Clinical trials #Drug discovery #Oncology

Trial will assess precision therapeutic vaccine in oesophageal cancer 

Infinitopes has announced that the first patient has been dosed with ITOP1, the company’s lead investigational therapeutic cancer vaccine candidate.  This marks the first clinical evaluation of Infinitopes’ Precision Immunomics platform, which combines large-scale immunopeptidomic antigen discovery with engineered viral vector technologies, to identify naturally presented tumour antigens capable of generating durable anti-tumour T-cell responses. Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (10-14 August 2026) 

News round-up for 10-14 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new discoveries in cancer research, including the first trial of a new type of immunotherapy, an immune cell finding that could transform cancer treatment, and a groundbreaking drug… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (3-7 August 2026) 

News round-up for 3-7 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new clinical trial results that demonstrate positive outcomes in Parkinson’s, colorectal cancer and Bundibugyo ebolavirus, as well as the first ever trial of a fridge-free vaccine. Elsewhere,… Read More

#News